RN7SL520P

Across TCGA pan-cancer cohorts, RN7SL520P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RN7SL520P’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where RN7SL520P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL520P is over-expressed in tumor, although a few such as LUSC show the opposite, repressed pattern.

LUAD, KICH, and LUSC are the cancer types where RN7SL520P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL520P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	IV	+0.405	.007	2	view →
KICH	Female	II,III,IV	+0.137	.049	1	view →
LUSC	All	II,III,IV	−0.103	.045	1	view →
KIRC	All	II,III,IV	+0.064	.047	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

RN7SL520P–LUAD

Open the LUAD breakdown →